Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial
Authors:
- C. Michael GibsonCGC. Michael Gibson
- Ajay J. KirtaneAKAjay J. Kirtane
- Sabina A. MurphySMSabina A. Murphy
- Steve RohrbeckSRSteve Rohrbeck
- Venu MenonVMVenu Menon
- Jeffrey LinsJLJeffrey Lins
- Samer KazzihaSKSamer Kazziha
- Ivan RokosIRIvan Rokos
- Nicolas W. ShammasNSNicolas W. Shammas
- Theresa M. PalabricaTPTheresa M. Palabrica
- Polly FishPFPolly Fish
- Carolyn H. McCabeCMCarolyn H. McCabe
- 1 October 2006
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 152 (4) , 668-675
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Times to Treatment in Transfer Patients Undergoing Primary Percutaneous Coronary Intervention in the United StatesCirculation, 2005
- Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarctionThe American Journal of Cardiology, 2005
- Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion ? results of the Austrian multi-centre randomized ReoPro-BRIDGING StudyEuropean Heart Journal, 2004
- ?Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trialEuropean Heart Journal, 2004
- Adjunctive Platelet Glycoprotein IIb/IIIa Receptor Inhibition With Tirofiban Before Primary Angioplasty Improves Angiographic OutcomesCirculation, 2003
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsThe Lancet, 2003
- Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplastyJACC, 1999
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsThe Lancet, 1994
- Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trialsThe American Journal of Cardiology, 1992
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985